Alinity m Resp-4-Plex AMP Kit, List Number 09N79-096, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test intended for the simultaneous qualitative detection and differentiation of RNA from SARS-CoV-2, influenza A virus (flu A), influenza B virus (flu B), and/or Respiratory Syncytial Virus (RSV) in anterior nasal or nasopharyngeal swab specimens collected by a healthcare provider (HCP), or in anterior nasal swab specimens that are self-collected at a healthcare location, from individuals suspected by their HCP of respiratory viral infection consistent with COVID-19.
FDA Recall Z-1749-2025 · Posted 2025-05-12
Advertisement
Recalling FirmAbbott Molecular, Inc.
Recall StatusOpen, Classified
Product CodeQJR
Date Initiated2025-04-28
Product Quantity656 units
Reason for Recall
There were reports of an increase in reactive negative controls and false positive results.
Firm Action
An Urgent Field Safety Notice/ Field Correction Recall notification letter dated 4/24/25 was sent to customers.
Necessary Actions:
" Discard inventory of the lot listed in the above table. Contact Abbott Customer Support for replacement of any unused kit(s).
" If you have forwarded any kits of this lot to other laboratories, please inform them of this
Urgent Field Safety Notice / Field Correction Recall and provide a copy of this letter.
" Return the associated Customer Reply form.
Please review this information with laboratory personnel and retain this communication for
future reference. If you have any questions regarding this communication, please contact your local Abbott representative, or call Abbott Technical Support at 1-800-553-7042 Option 2. We apologize for any inconvenience this may have caused your laboratory.
Root Cause
Under Investigation by firm
Distribution Pattern
Worldwide - US Nationwide distribution.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement